about
Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does notMusculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in JapanComparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trialEffect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort studyCombination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritisInterleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis
P50
Q33688001-D71CF18E-192D-4B20-9B76-C2EB40A6F63CQ58610581-44EBCD6E-7464-437C-AC30-B71634D3406AQ59336394-081164B3-17DC-44D7-969C-9A519CE20854Q60926780-26EC887D-03EA-48C4-8EAD-10B5CA9C0DB2Q89025878-3DD6CEB2-D175-4CFF-B98D-7431DE113DDDQ92439633-78DF0AE6-F811-4C04-88B1-7074E0CEE165Q94545245-52E63E05-A9B8-4483-BBEB-A7CF9051CEE3
P50
description
researcher
@en
wetenschapper
@nl
name
Tomohiro Koga
@en
Tomohiro Koga
@nl
type
label
Tomohiro Koga
@en
Tomohiro Koga
@nl
prefLabel
Tomohiro Koga
@en
Tomohiro Koga
@nl
P31
P496
0000-0003-2077-4428